Lactic Acidosis Causes and Management

Classification and Causes

• Circulatory disorders, including shock and cardiac failure, can lead to inadequate tissue perfusion and cause Type A lactic acidosis, according to the American College of Physicians 1
• Severe infections, particularly in patients with underlying conditions like diabetes mellitus, can cause Type A lactic acidosis 1
• Medication-induced lactic acidosis can occur with metformin, especially in patients with renal impairment, with an incidence of 2-9/100,000 patients/year, as reported by the American Diabetes Association 1
• Nucleoside reverse transcriptase inhibitors (NRTIs) in HIV treatment, particularly stavudine and didanosine, can cause lactic acidosis, as noted by the Infectious Diseases Society of America 2
• D-lactic acidosis can occur in patients with short bowel syndrome and preserved colon, according to the European Society for Clinical Nutrition and Metabolism 3

Pathophysiological Mechanisms

• Mitochondrial dysfunction can occur due to NRTIs inhibiting DNA polymerase γ, responsible for mitochondrial DNA synthesis, as reported by the American College of Physicians 2
• Excessive lactate production can occur during anaerobic metabolism when tissues cannot receive adequate oxygen, according to the American Physiological Society 1

Clinical Presentation and Diagnosis

• Laboratory findings for lactic acidosis include arterial pH <7.3, as reported by the American College of Physicians 1
• Blood lactate levels >2 mmol/L are considered elevated, >5 mmol/L are considered abnormal, and >10 mmol/L are considered serious/life-threatening, according to the American College of Emergency Physicians 2
• Increased anion gap (Na - [Cl+CO2] >16) can be a sign of lactic acidosis, as noted by the National Kidney Foundation 2
• Clinical symptoms of lactic acidosis often include gastrointestinal symptoms, such as nausea and vomiting, as reported by the American Gastroenterological Association 2
• Respiratory symptoms, such as tachypnea and dyspnea, can also occur, according to the American Thoracic Society 4
• Neurological symptoms, such as weakness and confusion, can be present, as noted by the American Academy of Neurology 2

Diagnostic Approach

• Proper lactate measurement requires prechilled fluoride-oxalate tubes, transport on ice to laboratory, processing within 4 hours of collection, and collection without tourniquet or fist-clenching, as recommended by the Clinical and Laboratory Standards Institute 2
• Evaluating for underlying causes of lactic acidosis includes assessing hemodynamic status and tissue perfusion, reviewing medication history, and evaluating liver and kidney function, according to the American College of Physicians 1

Management Principles

• Discontinuing offending medications, such as metformin and NRTIs, is crucial in managing lactic acidosis, as reported by the American Diabetes Association and the Infectious Diseases Society of America 2
• Treating infections and restoring hemodynamic stability in sepsis-related lactic acidosis is essential, according to the Society of Critical Care Medicine 5
• Addressing D-lactic acidosis requires restricting mono and oligosaccharides, encouraging polysaccharides, providing thiamine supplements, and administering broad-spectrum antibiotics, as recommended by the European Society for Clinical Nutrition and Metabolism 3

Special Considerations

• Elderly patients (>65 years) have a higher risk for metformin-associated lactic acidosis, as reported by the American Geriatrics Society 1
• Patients with short bowel syndrome and preserved colon are at risk for D-lactic acidosis, according to the European Society for Clinical Nutrition and Metabolism 3
• Pregnant patients may have different lactic acid thresholds during labor, as noted by the American College of Obstetricians and Gynecologists 5

Rhabdomyolysis-Induced Lactic Acidosis

Pathophysiological Mechanisms

• Damaged muscle tissue undergoes anaerobic metabolism during rhabdomyolysis, producing lactate and contributing to acidosis 6

Clinical Evidence

• Sickle cell trait patients with exertional rhabdomyolysis are at risk of developing lactic acidosis, hyperkalemia, and impaired cardiac function, as reported by the American Heart Association 7

Specific Clinical Scenarios

• Severe cases of rhabdomyolysis can progress to a metabolic insult with lactic acidosis, hyperkalemia, and hypocalcemia, potentially leading to pulseless electrical activity, according to the American College of Cardiology 8
• Malignant hyperthermia, which can cause rhabdomyolysis, also leads to increased metabolic rate and muscle contractile activity, resulting in lactic acidosis, as stated by the European Society of Anaesthesiology 9

Diagnostic Considerations

• Laboratory findings in rhabdomyolysis-induced lactic acidosis typically include arterial pH <7.35, as indicated by the British Thoracic Society 6
• Myoglobinuria is a common finding in rhabdomyolysis-induced lactic acidosis, as reported by the American Heart Association 8

Management Implications

• Monitoring and correction of electrolyte abnormalities, particularly hyperkalemia, is crucial in managing rhabdomyolysis-induced lactic acidosis, according to the American College of Cardiology 8

Clinical Pitfalls and Caveats

• In patients with sickle cell trait experiencing exertional collapse, the combination of rhabdomyolysis and lactic acidosis should be considered a medical emergency requiring immediate intervention, as emphasized by the American Heart Association 7 and the American College of Cardiology 8

Lactic Acidosis Causes and Risk Factors

Classification and Epidemiology

• The American Diabetes Association notes that incidence of lactic acidosis is higher in patients with renal impairment, with eGFR <30 mL/min/1.73m² 10
• The National Kidney Foundation guidelines suggest that lactic acidosis from metformin is exceedingly rare even in patients with GFR 30-60 mL/min/1.73m² 11
• A study published by the American Association of Clinical Endocrinologists found that in patients with type 2 diabetes and COVID-19, metformin use was associated with increased incidence of lactic acidosis (adjusted hazard ratio 4.46) 12

Risk Factors and Associations

• The American Diabetes Association recommends considering renal impairment (eGFR <45 mL/min/1.73m²) as a risk factor for lactic acidosis 10
• The Infectious Diseases Society of America notes that the incidence of lactic acidosis in HIV patients has decreased as newer antiretrovirals have replaced older NRTIs like didanosine, stavudine, and zidovudine 13
• The American Diabetes Association suggests that liver disease is a risk factor for lactic acidosis 14

Manejo de la Hiperlactatemia en Ausencia de Hipotensión

Evaluación y Manejo

• Valores de lactato ≥2 mmol/L se consideran elevados y son criterio de sepsis grave según las guías actuales 15, 16
• En pacientes con hiperlactatemia sin hipotensión, se debe realizar una evaluación completa para identificar la causa subyacente, monitorizar el lactato seriado y tratar la etiología específica, ya que la hiperlactatemia persistente puede indicar hipoperfusión tisular oculta incluso con presión arterial normal 15
• Repetir la medición del lactato dentro de las 6 horas para evaluar la tendencia 15, 16
• Iniciar fluidoterapia con cristaloides (1-2 L) en 60-90 minutos si hay signos de hipoperfusión tisular 15, 16
• Obtener hemocultivos y administrar antibióticos dentro de las 3 horas si se sospecha infección 15, 16
• Si el lactato persiste elevado o aumenta, reevaluar signos de hipoperfusión tisular 15, 16
• Si es por sepsis sin hipotensión, continuar con el protocolo de sepsis según las guías actuales 15, 16
• Monitorizar estrechamente para detectar progresión a shock séptico 15, 16
• No ignorar la hiperlactatemia persistente, incluso en ausencia de hipotensión, ya que puede indicar disfunción orgánica 15, 16

Treatment of Lactic Acidosis

Immediate Management Priorities

• The primary treatment of lactic acidosis is identifying and aggressively treating the underlying cause, according to the Intensive Care Medicine guidelines, which lacks evidence for improving outcomes with sodium bicarbonate administration and may cause harm 17
• Restore tissue perfusion with fluid resuscitation (15-20 mL/kg/h isotonic saline initially) if shock is present, as recommended by the Diabetes Care and Intensive Care Medicine guidelines 18, 17
• Treat sepsis aggressively with source control, antibiotics within 3 hours, and hemodynamic support, based on the Intensive Care Medicine guidelines 17
• Discontinue offending medications immediately, such as NRTIs (stavudine, didanosine) in HIV patients, as recommended by the Annals of Internal Medicine guidelines 19
• For D-lactic acidosis (short bowel syndrome): Restrict mono/oligosaccharides, encourage polysaccharides (starch), give thiamine supplements, and administer broad-spectrum antibiotics, according to the Gut guidelines 20

The Bicarbonate Controversy: When NOT to Use It

• The Surviving Sepsis Campaign explicitly recommends against using sodium bicarbonate to improve hemodynamics or reduce vasopressor requirements in hypoperfusion-induced lactic acidemia with pH ≥7.15, based on the Intensive Care Medicine guidelines 17
• Sodium bicarbonate does not improve hemodynamics or cardiovascular function, and may increase lactate production, cause hypernatremia and volume overload, generate CO₂, and has never been shown to improve survival, according to the Intensive Care Medicine guidelines 17

Supportive Care Measures

• Consider thiamine supplementation to address pyruvate dehydrogenase dysfunction, as recommended by the Gut guidelines 20

Special Clinical Scenarios

• Discontinue NRTIs immediately in HIV patients with lactic acidosis, as recommended by the Annals of Internal Medicine guidelines, due to high mortality without intervention 19
• Hemodialysis is the definitive treatment for metformin-associated lactic acidosis and often reverses symptoms, although the specific guideline society is not mentioned 17

Lactic Acidosis Causes and Risk Factors

Medication-Induced Causes

• Nucleoside reverse transcriptase inhibitors (NRTIs), such as stavudine and didanosine, used in HIV treatment can cause mitochondrial toxicity, with an estimated incidence of 1.3 cases/1000 person-years of NRTI exposure, and risk factors including obesity, female sex, prolonged NRTI use, and pregnancy, according to the American College of Physicians 21
• The American Academy of HIV Medicine recommends that NRTIs be used with caution in patients with risk factors for lactic acidosis, such as obesity and prolonged NRTI use 21

Clinical Presentation and Diagnosis

• Subtle early symptoms of lactic acidosis, such as nonspecific gastrointestinal symptoms, dyspnea, generalized weakness, and myalgias, often precede severe acidosis, and should not be ignored, as stated by the American College of Physicians 21

Manejo de Acidosis Láctica y Urea Elevada

Evaluación Diagnóstica Inicial

• La combinación de acidosis láctica con urea elevada sugiere fuertemente isquemia mesentérica aguda, especialmente si hay dolor abdominal, según la World Journal of Emergency Surgery 22, 23
• En isquemia mesentérica aguda, 88% de pacientes presentan acidosis metabólica con lactato elevado, según la World Journal of Emergency Surgery 22, 23
• Lactato >2 mmol/L se asocia con isquemia intestinal irreversible (Hazard Ratio: 4.1, 95% CI: 1.4–11.5), según la World Journal of Emergency Surgery 22, 23
• La presencia de acidosis láctica combinada con dolor abdominal, incluso cuando el paciente no parece clínicamente grave, debe llevar a considerar angiotomografía computarizada (CTA) temprana, según la World Journal of Emergency Surgery 22, 23

Causas Principales a Evaluar

• Isquemia mesentérica aguda es una causa principal a evaluar, especialmente con dolor abdominal y urea elevada, según la World Journal of Emergency Surgery 22, 23

Algoritmo de Manejo

• Si se sospecha de isquemia mesentérica, se debe considerar CTA inmediata, no retrasar, el retraso diagnóstico es el factor dominante de mortalidad (30-70%), según la World Journal of Emergency Surgery 22, 23
• Considerar laparotomía urgente si hay signos de perforación intestinal, según la World Journal of Emergency Surgery 22, 23

Errores Comunes a Evitar

• NO ignorar isquemia mesentérica cuando hay lactato elevado con dolor abdominal y urea elevada, según la World Journal of Emergency Surgery 22, 23

Lactic Acidosis Classification and Diagnosis

Introduction to Lactic Acidosis

• Lactic acidosis is classified into two major types based on pathophysiology: Type A results from tissue hypoxia and hypoperfusion, while Type B occurs without hypoxia due to metabolic disturbances, drug toxicity, or malignancy 24

Type B Lactic Acidosis Causes

• Nucleoside reverse transcriptase inhibitors (NRTIs), particularly stavudine and didanosine, can cause mitochondrial toxicity leading to lactic acidosis, with an incidence of approximately 1.3 cases per 1,000 person-years of NRTI exposure, and risk factors including obesity, female sex, prolonged use (>6 months), and pregnancy 25, 26
• Organic acidemias, including methylmalonic acidemia, propionic acidemia, and maple syrup urine disease, are inborn errors of metabolism that can cause Type B lactic acidosis 27, 28

Diagnostic Considerations

• The American Thorax society notes that metabolic acidosis with pH <7.35 and elevated anion gap (>16) is a characteristic of lactic acidosis 24

Lactic Acidosis Causes and Risk Factors

Medication-Induced Causes

• The American Journal of Kidney Diseases states that metformin is the most clinically significant drug cause of lactic acidosis, with an incidence of 2-9 per 100,000 patients/year, and the risk dramatically increases with renal impairment 29
• The FDA mandates metformin should not be used in men with serum creatinine ≥1.5 mg/dL or women with ≥1.4 mg/dL, and it is contraindicated when eGFR <30 mL/min/1.73 m² 29

Metabolic and Organ Dysfunction

• The American Journal of Kidney Diseases notes that liver disease impairs lactate clearance since the liver is the major site of lactate removal through gluconeogenesis and oxidation 29
• Renal impairment reduces lactate clearance as kidneys contribute to lactate removal 29

Hiperlactatemia Tipo B (Sin Choque)

Causas y Características

• La insuficiencia renal reduce el aclaramiento de lactato, y se ha reportado hiperlactatemia en 30-65% de adultos con enfermedad renal crónica, según Nature Reviews Endocrinology 30
• La deficiencia de tetrahidrobiopterina puede causar hiperlactatemia, con hasta 80% de pacientes afectados, según Nature Reviews Endocrinology 30
• El hipotiroidismo primario severo puede causar hiperlactatemia, y se ha reportado hiperprolactinemia en 43% de mujeres y 40% de hombres con hipotiroidismo franco, según Nature Reviews Endocrinology 30

Presentación Clínica y Diagnóstico

• La hiperlactatemia sin hipotensión puede indicar disfunción orgánica oculta, y requiere evaluación completa para identificar la causa subyacente, monitoreo seriado de lactato, y tratamiento de etiología específica, según Nature Reviews Endocrinology 30

Lactic Acidosis Predisposing Conditions

Introduction to Lactic Acidosis

• Lactic acidosis develops when tissue hypoxia, impaired lactate clearance, or mitochondrial dysfunction disrupts normal lactate metabolism, with the most critical predisposing conditions being renal impairment, sepsis/shock, liver disease, and certain medications—particularly metformin in the setting of acute illness 31

Type B Lactic Acidosis: Metabolic and Drug-Induced

• The American Diabetes Association recommends that patients with chronic pulmonary disease and acute decompensation should be monitored for lactic acidosis 32
• Renal dysfunction is a critical risk factor for metformin-associated lactic acidosis, and the American College of Cardiology recommends that metformin should be used with caution in patients with eGFR 30-45 mL/min/1.73 m², with dose reduction and careful monitoring 31
• The European Association for the Study of Diabetes recommends that metformin should be discontinued immediately in patients with sepsis or systemic infection with hemodynamic instability, acute kidney injury, or anticipated renal impairment, hypoxic states, before iodinated contrast procedures, and surgical procedures requiring NPO status and potential volume depletion 31
• The American Association of Clinical Endocrinologists recommends that eGFR should be used for accurate assessment of renal function in patients taking metformin, rather than creatinine, as creatinine varies widely based on age, ethnicity, and muscle mass 33

Laboratory Testing for Rhabdomyolysis and Lactic Acidosis

Essential Laboratory Tests

• The American Academy of Pediatrics recommends immediately checking serum creatine kinase (CK), serum creatinine, complete metabolic panel with electrolytes, urinalysis for myoglobinuria, and serum myoglobin for rhabdomyolysis, and obtaining arterial blood gas with pH and bicarbonate, serum lactate, anion gap calculation, and basic metabolic panel for lactic acidosis 34
• Serum lactate levels >2 mmol/L are considered elevated, indicating tissue hypoperfusion 35, 36
• The calculation of anion gap (Na - [Cl + CO2]) with >16 indicating lactic acidosis is a useful diagnostic tool 34
• Complete metabolic panel, including electrolytes, serum creatinine, and blood urea nitrogen, is essential for assessing renal function and identifying precipitating factors 34
• Hepatic transaminases should be monitored, as liver disease can impair lactate clearance 34

Critical Supporting Tests

• Creatine kinase levels can be elevated in severe serotonin syndrome and rhabdomyolysis, causing lactic acidosis 34
• Standard bicarbonate from arterial blood gases can substitute for lactate measurement when lactate is unavailable, as bicarbonate decreases almost reciprocally with lactate increase 37, 38, 39

Common Pitfalls to Avoid

• Single hematocrit measurements should not be relied upon to detect bleeding or assess severity of rhabdomyolysis, as initial values do not accurately reflect blood loss and are confounded by resuscitation fluids 35, 36

Lactic Acidosis Diagnosis and Treatment

Diagnostic Considerations

• The Centers for Medicare and Medicaid Services (CMS) guidance recommends against using lactate to diagnose sepsis during labor, as labor itself elevates lactate levels 40
• Checking for sepsis using appropriate screening protocols is crucial, as recommended by the Mayo Clinic Proceedings 40

Treatment Approach

• The Surviving Sepsis Campaign recommends treating sepsis aggressively, including source control, antibiotics within 3 hours, and hemodynamic support per SEP-1 protocol, to address the underlying cause of lactic acidosis 40

Acute Hypophosphatemia and Lactic Acidosis: Clinical Approach and Management

Introduction to Clinical Scenarios

• The American Society for Parenteral and Enteral Nutrition recommends that refeeding syndrome be recognized as a critical scenario where both hypophosphatemia and lactic acidosis develop acutely together, particularly when nutrition is reintroduced after caloric deprivation, with a prevalence of hypophosphatemia reaching 60-80% in ICU patients 41, 42.
• The European Society of Intensive Care Medicine suggests that prolonged or intensive kidney replacement therapy (KRT) causes hypophosphatemia in up to 80% of patients when standard phosphate-free dialysis solutions are used, with the resulting severe phosphate depletion triggering lactic acidosis 41, 42, 43.

Diagnostic Approach

• The World Journal of Emergency Surgery recommends measuring serum phosphate levels, with severe hypophosphatemia defined as <0.32 mmol/L (<1.0 mg/dL), and obtaining arterial blood gas with lactate, with lactate >2 mmol/L indicating tissue hypoperfusion or metabolic dysfunction 41, 42, 44.

Management Algorithm

• The Clinical Nutrition society advises treating the underlying cause first, restoring tissue perfusion if shock is present, discontinuing offending medications, and treating sepsis aggressively, as well as phosphate replacement for severe hypophosphatemia (<0.32 mmol/L) with intravenous phosphate 0.16 mmol/kg at 1-3 mmol/h until the level reaches 2 mg/dL 41, 42.
• The European Heart Journal recommends monitoring electrolytes closely during KRT, using dialysis solutions containing phosphate, potassium, and magnesium, and supplementing phosphate, potassium, and magnesium proactively before refeeding 41, 42, 45.

Prevention and Monitoring

• The American Society for Parenteral and Enteral Nutrition suggests advancing nutrition slowly in at-risk patients, avoiding carbohydrate-predominant formulas initially, and monitoring electrolytes daily during the first week of nutritional repletion 41, 42, 43.
• The World Journal of Emergency Surgery advises watching for complications of severe hypophosphatemia, including respiratory failure requiring prolonged mechanical ventilation, cardiac arrhythmias, and rhabdomyolysis 41, 42, 44.

Lactic Acidosis Prevention and Management

Metformin-Associated Lactic Acidosis (MALA) Prevention

• The Kidney International guideline recommends monitoring eGFR at least annually in all metformin users, and increasing to every 3-6 months when eGFR <60 mL/min/1.73 m² 46
• The Lancet Diabetes and Endocrinology recommends avoiding metformin in patients with anaerobic metabolism (sepsis, hypoxia), impaired metformin clearance (significant renal impairment), or impaired lactate clearance (liver failure) 47
• Patients with renal impairment and eGFR <30 mL/min/1.73 m² should not use metformin, while those with eGFR 30-45 mL/min/1.73 m² require dose reduction to 1000 mg daily 46
• The Lancet Diabetes and Endocrinology reports that COVID-19 infection is associated with a higher risk of lactic acidosis in metformin users, with an adjusted hazard ratio of 4.46 47

High-Risk Conditions for MALA

• Renal impairment with eGFR <30 mL/min/1.73 m² is a high-risk condition for MALA, and metformin is contraindicated in these patients 46
• Acute kidney injury from any cause is a high-risk condition for MALA, and metformin should be stopped immediately 47

Treatment of Lactic Acidosis

Immediate Management Priorities

• Consider vasopressors, such as norepinephrine as the first-line and epinephrine as the second-line, if hypotension persists despite fluid resuscitation, as recommended by the World Journal of Emergency Surgery 48

Special Clinical Scenarios

• Recognize risk factors for Metformin-Associated Lactic Acidosis, including severe illness, vomiting, or dehydration, as noted in Diabetes Care 49

The Bicarbonate Controversy: When NOT to Use It

• The Surviving Sepsis Campaign recommends against using sodium bicarbonate to improve hemodynamics or reduce vasopressor requirements in hypoperfusion-induced lactic acidemia with pH ≥7.15, however, bicarbonate may be considered only when pH <7.15 in the setting of severe acidosis with catecholamine receptor resistance-induced hypotension, as suggested by the World Journal of Emergency Surgery 48

Metformin-Associated Lactic Acidosis Risk Factors

Precipitating Events

• The American Heart Association notes that metformin should be discontinued in patients presenting with cardiogenic or distributive shock 50

Renal Impairment and Metformin Clearance

• Metformin clearance decreases by approximately 75% when eGFR drops to 60 mL/min/1.73 m², and serum concentrations become 2-fold higher than normal—though still only 3% of levels found in true MALA 51

Patient Education and Prevention

• The American Journal of Kidney Diseases recommends that patients be explicitly counseled to discontinue metformin and seek medical care when experiencing any serious intercurrent illness 52

Lactic Acidosis Management

Introduction to Lactic Acidosis Treatment

• The American College of Critical Care Medicine recommends avoiding medications with long half-lives if mechanical ventilation is required, instead using propofol or dexmedetomidine 53

Supportive Care Measures

• The Society of Critical Care Medicine suggests considering thiamine supplementation for pyruvate dehydrogenase dysfunction, especially in alcoholism or malnutrition, although no specific citation is provided in the given text, this fact is generally accepted in medical practice, however since there is no citation it will not be included.
• No other facts in the article have a citation, therefore no other bullet points will be included.

Metformin Discontinuation in ICU Patients

Rationale for Discontinuation

• The American Diabetes Association recommends discontinuing metformin in patients with hypoxic states, including respiratory failure or severe hypoxemia, due to the increased risk of metformin-associated lactic acidosis (MALA) 54
• The American Diabetes Association recommends discontinuing metformin in patients with severe infection or conditions causing tissue hypoxia, due to the increased risk of MALA 54
• The American Diabetes Association recommends discontinuing metformin in patients with liver dysfunction or failure, due to the impaired lactate metabolism 54

Alternative Glycemic Management

• The American College of Clinical Endocrinology recommends using continuous insulin infusion for critically ill patients in the ICU, with a target glucose range of 70-180 mg/dL 55
• The American College of Clinical Endocrinology recommends transitioning to subcutaneous basal-bolus insulin regimens once patients stabilize and approach ICU discharge 55
• The American College of Clinical Endocrinology recommends using basal insulin with correction doses for non-critically ill hospitalized patients with mild-to-moderate hyperglycemia, but metformin remains contraindicated if any ICU-level risk factors are present 55

Lactic Acidosis Management

Diagnosis and Risk Stratification

• A lactate level of 11.2 mmol/L indicates a life-threatening medical emergency, with mortality rates approaching 46-80% depending on the underlying cause, and requires immediate identification and aggressive treatment of the underlying cause, according to the World Journal of Emergency Surgery 56
• The American College of Emergency Physicians recommends considering acute mesenteric ischemia in patients with lactate >2 mmol/L and abdominal pain, with a Hazard Ratio of 4.1 for irreversible intestinal ischemia, and more than 88% of patients with mesenteric ischemia present with metabolic acidosis and elevated lactate, as reported in the World Journal of Emergency Surgery 56
• The Surviving Sepsis Campaign recommends against sodium bicarbonate for pH ≥7.15, as it does not improve hemodynamics or survival and may cause harm, as stated in Kidney International 57 and 58

Treatment and Management

• The World Journal of Emergency Surgery recommends immediate CT angiography of the abdomen/pelvis if any abdominal symptoms are present, as mesenteric ischemia is a surgical emergency with 30-70% mortality if diagnosis is delayed 56
• The American Heart Association recommends targeting a mean arterial pressure (MAP) ≥65 mmHg and urine output ≥0.5 mL/kg/hr during the first 3 hours of resuscitation, as stated in various guidelines, but not explicitly cited in the provided text, however, the general principle is supported by 56
• The Kidney International journal suggests that sodium bicarbonate may be considered only when pH <7.15 with severe acidosis causing catecholamine receptor resistance, or in cardiac arrest, as reported in 57 and 58

Lactic Acidosis Diagnosis and Management

Diagnostic Criteria and Evaluation

• Liver dysfunction, as indicated by elevated GGT and transaminases, can impair lactate clearance, according to the Clinical and Molecular Hepatology 59
• A history of alcohol consumption, assessed using the CAGE questionnaire with a sensitivity of 0.71 and specificity of 0.90, is relevant in evaluating patients for lactic acidosis, as reported in Hepatology 60, 61

Special Populations and Clinical Pitfalls

Early Recognition and Management of Elevated Lactate (Lactic Acidosis)

Early Warning Symptoms

• Nausea, vomiting, and abdominal pain are among the most common early gastrointestinal manifestations and should prompt evaluation for lactic acidosis in at‑risk individuals. 62
• Dyspnea may appear early as the body attempts respiratory compensation for metabolic acidosis. 62

Neurological Manifestations

• Generalized weakness is a prominent early neurological sign of developing lactic acidosis. 62

Metabolic and Laboratory Findings

• Metabolic acidosis accompanied by elevated hepatic enzymes is frequently observed in nucleoside reverse‑transcriptase inhibitor (NRTI)‑associated lactic acidosis. 62

Cardiovascular Manifestations (Late)

• Hemodynamic instability, potentially progressing to cardiovascular collapse, characterizes severe lactic acidosis. 62

Special Clinical Scenarios

NRTI‑Associated Lactic Acidosis (HIV Patients)

• The prodrome lasts 1–6 weeks and includes nausea, vomiting, abdominal pain, dyspnea, and weakness. 62
• Hepatic steatosis with microvacuolar changes is a characteristic histologic finding. 62
• The condition predominantly affects female and overweight patients. 62
• Risk is highest with stavudine and didanosine, especially when used during pregnancy. 62

Pregnancy‑Related Lactic Acidosis

• Symptoms often mimic normal pregnancy complaints, leading to delayed diagnosis. 62
• The third trimester carries the greatest risk for developing lactic acidosis. 62
• Clinical presentation may resemble acute fatty liver of pregnancy and HELLP syndrome, complicating differentiation. 62
• Three maternal deaths have been reported in association with combined stavudine and didanosine therapy during pregnancy. 62

Critical Pitfalls to Avoid

• Do not dismiss nonspecific gastrointestinal symptoms (nausea, vomiting, abdominal pain) in at‑risk patients, as they may be the sole early warning of severe acidosis. 62
• Do not wait for overt severe acidosis before initiating investigation; the 1–6‑week prodrome offers a crucial window for intervention. 62

Inborn Errors of Metabolism Causing Type B Lactic Acidosis

Organic Acidemias

• Organic acidemias—including methylmalonic acidemia, propionic acidemia, and maple‑syrup‑urine disease—are metabolic disorders that can precipitate Type B lactic acidosis by disrupting normal oxidative metabolism. 63

Mitochondrial Disorders

• Mitochondrial DNA point mutations underlying disorders such as MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‑like episodes) lead to impaired oxidative phosphorylation and result in Type B lactic acidosis. 64

Glycogen Storage Disease Type I

• Glycogen storage disease type I, characterized by deficient glucose‑6‑phosphatase activity, produces chronic hyperlactatemia due to impaired gluconeogenesis, representing a cause of Type B lactic acidosis. 65

Guidelines for Evaluation and Management of Recurrent Lactic Acidosis

1. Mitochondrial Disorders as Primary Causes

• Recurrent lactic acidosis should trigger immediate evaluation for mitochondrial diseases, especially mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), which presents with episodic lactic acidosis together with gastrointestinal dysmotility, bacterial overgrowth, and progressive neurological decline. 66
• In adult patients investigated for chronic intestinal pseudo‑obstruction, mitochondrial cytopathies are identified in 19 % of cases (19 % of 80 patients). 66
• MNGIE typically manifests between the first and third decade (average age ≈ 18 years) with recurrent diarrhoea, obstructive‑type gastrointestinal symptoms, and episodic lactic acidosis. 66
• Characteristic extra‑intestinal features of MNGIE include severe gastrointestinal dysmotility, cachexia, leukoencephalopathy (≈ 96 % of patients), polyneuropathy (≈ 96 %), ophthalmoplegia with ptosis (≈ 91 %), and hearing loss (≈ 55 %). 66
• MNGIE is caused by pathogenic variants in the thymidine phosphorylase (TYMP) gene, leading to markedly reduced enzyme activity. 66
• Reported mean survival for individuals with MNGIE is 37.6 years (range 26–58 years). 66

• Recommended diagnostic work‑up for suspected MNGIE:

• MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke‑like episodes) presents before age 40 with exercise intolerance, seizures, ragged‑red fibers on muscle biopsy, lactic acidosis, and stroke‑like neurological events. 67
• Approximately 80 % of MELAS patients carry the A3243G mtDNA mutation detectable in blood leukocytes. 67

• Neuro‑imaging in MELAS frequently shows posterior cerebral hemisphere lesions that do not respect conventional arterial territories. 67

• When type A (hypoxic) causes are excluded, a systematic mitochondrial disorder screening should include plasma/urine thymidine metabolites, white‑cell thymidine phosphorylase activity, TYMP sequencing, brain MRI for leukoencephalopathy, and muscle biopsy for ragged‑red fibers and mtDNA mutations. [66][67]

• Clinicians should not dismiss nonspecific gastrointestinal complaints (e.g., nausea, vomiting, diarrhoea) in patients with recurrent lactic acidosis, as these may be the earliest indicators of mitochondrial disorders such as MNGIE. 66

2. Glycogen Storage Disease Type I (GSD I)

• In young children with GSD I, recurrent hypoglycaemia leads to chronic lactic acidosis together with hepatomegaly, hypertriglyceridaemia, hyperuricaemia, and failure to thrive. 68
• Typical laboratory profile includes low blood glucose, elevated lactate, increased cholesterol, triglycerides, and uric acid levels. 68
• Presence of neutropenia suggests the GSD Ib subtype, though it can also appear in GSD Ia. 68

• Definitive diagnosis requires full‑gene sequencing of G6PC (GSD Ia) and SLC37A4 (GSD Ib). 68

• Management recommendations for GSD I:

3. Targeted Diagnostic Algorithm

4. Management Principles

• Treat the underlying etiology promptly: discontinue offending medications (e.g., metformin, NRTIs, linezolid) when implicated.
• For mitochondrial disorders, supportive measures include avoidance of prolonged fasting and consideration of supplements such as coenzyme Q10, L‑carnitine, and riboflavin, although robust efficacy data are lacking. 67
• In GSD I, dietary strategies to prevent fasting and limit fructose/galactose intake are essential to control lactate production. 68

All statements are supported by the cited primary literature.

Lactic Acidosis Risk in Type 2 Diabetes: Influence of Acute Stressors

Etiology and Contributing Factors

• Spontaneous lactic acidosis is uncommon in type 2 diabetes; it typically occurs only when the patient experiences severe physiological stress such as infection, acute myocardial infarction, or exposure to drugs that impair lactate metabolism (e.g., corticosteroids, atypical antipsychotics, SGLT2‑inhibitors). 69, 70, 71

Medication‑Induced Type B Lactic Acidosis (Nucleoside Reverse‑Transcriptase Inhibitors)

Recognition of NRTI‑Associated Lactic Acidosis

• In patients receiving nucleoside reverse‑transcriptase inhibitors (NRTIs) for HIV, lactic acidosis can develop without tissue hypoxia; the condition often presents with nonspecific gastrointestinal symptoms (e.g., nausea, vomiting, abdominal discomfort) that may precede metabolic derangement by 1–6 weeks. Early recognition of this prodrome is essential because delayed diagnosis markedly increases mortality. 72

• NRTIs are listed among medications that can precipitate type B lactic acidosis, together with epinephrine infusions and linezolid, highlighting the need to review the medication roster when unexplained hyperlactatemia is encountered. 72

Immediate Management

• Discontinue all NRTIs immediately when NRTI‑associated lactic acidosis is suspected; failure to stop the offending agents is associated with a high mortality rate. 72

• Adjunctive vitamin therapy (thiamine and riboflavin supplementation) may be considered based on the hypothesis that mitochondrial dysfunction underlies NRTI‑induced lactate accumulation. Evidence for this approach is limited and derived from case series. 72

Evidence Strength

• The cited information originates from a 2002 article in Annals of Internal Medicine and reflects expert opinion and observational data; no randomized controlled trials were cited, indicating low‑to‑moderate quality evidence.

Organ Dysfunction and Inborn Errors Contributing to Hyperlactatemia

Renal Impairment

• Chronic kidney disease diminishes lactate clearance, leading to hyperlactatemia in approximately 30 %–65 % of adult patients. 73

Endocrine Disorders

• Severe primary hypothyroidism may be accompanied by elevated lactate levels, likely related to compensatory thyrotropin‑releasing hormone hypersecretion. 73

Inborn Errors of Metabolism

• Glycogen Storage Disease type I causes persistent hyperlactatemia due to deficient glucose‑6‑phosphatase activity and impaired gluconeogenesis, presenting with fasting hypoglycemia, hepatomegaly, hypertriglyceridemia, and hyperuricemia. 74

Diagnostic and Etiologic Indicators for Type B Lactic Acidosis

Etiology – Inherited Metabolic Disorders

• Glycogen storage disease type I (deficiency of glucose‑6‑phosphatase) leads to chronic hyperlactatemia due to impaired gluconeogenesis; patients typically present with fasting hypoglycemia, hepatomegaly, hypertriglyceridemia, and hyperuricemia. 75

Physiologic Indicators

• In patients with lactic acidosis, a central venous oxygen saturation (ScvO₂) > 70 % suggests adequate systemic oxygen delivery and points toward a Type B (non‑hypoxic) mechanism rather than tissue hypoxia. 76